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a  b  s  t  r  a  c  t
Because  mitochondrial  oxidative  stress  and  impairment  are  important  mediators  of neuronal  damage  in
neurodegenerative  diseases  and  in brain  ischemia/reperfusion,  in  the present  study,  we evaluated  the
antioxidant  and mitoprotective  effect  of a new  promising  neuroprotective  molecule,  JM-20,  in mitochon-
dria  and  synaptosomes  isolated  from  rat  brains.  JM-20  inhibited  succinate-mediated  H2O2 generation
in  both  mitochondria  and  synaptosomes  incubated  in depolarized  (high  K+) medium  at  extremely  low
micromolar  concentration  and  with  identical  IC50 values  of  0.91  M.  JM-20  also  repressed  glucose-
induced  H2O2 generation  stimulated  by rotenone  or by  antimycin  A  in synaptosomes  incubated  in  high
sodium-polarized  medium  at extremely  low  IC50 values  of  0.395  M and  2.452  M, respectively.  JM-20
was  unable  to react  directly  with  H2O2 or with  superoxide  anion  radicals  but  displayed  a  cathodic  reduc-
tion  peak  at  −0.71  V, which  is close  to  that  of oxygen  (−0.8  V),  indicating  high  electron  afﬁnity.  JM-20
also  inhibited  uncoupled  respiration  in  mitochondria  or synaptosomes  and  was  a  more  effective  inhibitor
in the  presence  of  the  respiratory  substrates  glutamate/malate  than  in  the  presence  of succinate.  JM-20
also prevented  Ca2+-induced  mitochondrial  permeability  transition  pore  opening,  membrane  potential
dissipation  and  cytochrome  c release,  which  are  key  pathogenic  events  during  stroke.  This  molecule
also  prevented  Ca2+ inﬂux  into  synaptosomes  and  mitochondria;  the  former  effect  was  a consequence  of
the  latter  because  JM-20  inhibition  followed  the patterns  of  carbonyl  cyanide  p-triﬂuoromethoxyphenyl
hydrazone  (FCCP),  which  is a classic  mitochondrial  uncoupler.  Because  the mitochondrion  is considered
an important  source  and target  of neuronal  cell  death  signaling  after  an  ischemic  insult,  the  antioxidant
and  protective  effects  of  JM-20  against  the  deleterious  effects  of Ca2+ observed  at  the  mitochondrial  level
in this  study  may  endow  this  molecule  with  the  ability  to succeed  in mitochondrion-targeted  strategies
to combat  ischemic  brain  damage.
©  2014  Elsevier  Inc.  All  rights  reserved.∗ Corresponding author. Tel.: +535 2718534.
E-mail address: gilbertopardo@infomed.sld.cu (G.L. Pardo-Andreu).
ttp://dx.doi.org/10.1016/j.brainresbull.2014.10.001
361-9230/© 2014 Elsevier Inc. All rights reserved.1. IntroductionOxidative stress is implicated in the pathogenesis of progres-
sive neuron deterioration associated with excitotoxicity observed
in chronic and acute brain diseases or in aging (Chen et al., 2011;
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aig. 1. Chemical structure of JM-20 (3-ethoxycarbonyl-2-methyl-4-(2-
itrophenyl)-4,11-dihydro-1H-pyrido[2,3-b][1,5]benzodiazepine).
anzanero et al., 2013; Perluigi et al., 2013; Wang and Qin, 2010).
ecause mitochondria are the major sites for reactive oxygen
pecies (ROS) generation in neurons (Lin and Beal, 2006), these
rganelles are a focus for determining new neuroprotective agents;
vidence has accumulated that suggest a crucial role for mitochon-
rial defects in the pathogenesis of these conditions by initiating
nd promoting oxidative stress.
Recently, we obtained a new family of 1,5-benzodiaze-
ines that structurally differ from the currently available 1,5-
enzodiazepines due to the presence of a 1,4-dihydropyridine
oiety fused to the benzodiazepine ring. JM-20 (3-ethoxycarbonyl-
-methyl-4-(2-nitrophenyl)-4,11-dihydro-1H-pyrido[2,3-b][1,5]
enzodiazepine), which is a member of this compound family
Fig. 1), has an anxiolytic proﬁle similar to that of diazepam
Figueredo et al., 2013). At a low micromolar concentration,
e observed JM-20 prevents the Ca2+-induced mitochondrial
ermeability transition, membrane potential dissipation, and
ro-apoptotic protein cytochrome c release, and inhibits the
ydrolytic activity of F1F0-ATP synthase in rat liver mitochondria
Nun˜ez-Figueredo et al., 2014a). We  hypothesized that these mito-
rotective effects may  be involved in the neuroprotection elicited
y JM-20 in several in vitro models relevant to cerebral ischemia
Nun˜ez-Figueredo et al., 2014a). We  also reported an important
rotective effect of JM-20 against hydrogen peroxide (H2O2)- or
lutamate-induced PC-12 cell death or KCN-mediated chemical
ypoxia (Nun˜ez-Figueredo et al., 2014a). Because oxidative stress
nd mitochondrial impairment are key mediators of the ischemic
rocess, particularly after reperfusion (Chan, 2005; Niizuma et al.,
009), we examined the antioxidant effects of JM-20 in rat brain
itochondria and in a synaptosomal preparation. To support the
itoprotective hypothesis of JM-20 neuroprotection, we also
ssessed its mitoprotective effect on Ca2+-induced mitochon-
rial dysfunction using isolated mitochondria from rat brains.
e observed that JM-20 acts equally as a potent antioxidant
n mitochondria or in synaptosomes most likely due to its high
lectron-afﬁnity at the organelle level. Our results also indicate
hat the mitoprotection against Ca2+-mediated mitochondrial
mpairment may  involve Ca2+ uptake inhibition at the mitochon-
rial level, which could play a role in the mechanism of action of
M-20 as a neuroprotectant.
. Materials and methods
.1. Compounds and reagents
All chemicals and enzymes used were of the highest grade avail-
ble and were purchased from Sigma-Aldrich (St. Louis, MO,  USA),
nless otherwise speciﬁed. Stock solutions of JM-20 were prepared
aily in dimethyl sulfoxide (DMSO) and added to the reaction media
t 1/1000 (v/v) dilution. Control experiments contained DMSO at
/1000 dilution. JM-20 was synthesized, puriﬁed and characterized
s previously reported (Figueredo et al., 2013).rch Bulletin 109 (2014) 68–76 69
2.2. Isolation of synaptosomal preparation and mitochondria
The forebrains from male Wistar rats (3–4 months old) were
rapidly removed and homogenized in isolation buffer contain-
ing 0.32 M sucrose, 1 mM ethylenediaminetetraacetic acid (EDTA)
(K+ salt), and 10 mM Tris–HCl (pH 7.4). The homogenate was
centrifuged at 1330 × g for 3 min. The supernatant was  carefully
retained and centrifuged at 16,000 rpm (21,200 × g) for 10 min. The
pellet was  resuspended, carefully layered on the top of a discon-
tinuous Percoll gradient and centrifuged for 5 min  at 30,700 × g
(Sims, 1990; Sims and Anderson, 2008). The synaptosomal and
mitochondrial fractions were incubated in depolarized buffer (high
K+: 100 mM KCI, 75 mM mannitol, 25 mM  sucrose, 5 mM  phosphate,
0.05 mM EDTA, and 10 mM Tris–HCl, pH 7.4) and synaptosomal
was also incubated in polarized buffer (high Na+: 140 mM NaCl,
20 mM HEPES, 10 mM d-glucose, 1.2 mM Na2HPO4, 1 mM MgCl2,
5 mM NaHCO3, and 5 mM KCl, pH 7.4). The mitochondrial respira-
tory control ratio (state 3/state 4 respiratory rate ratio) was  over 5,
measured using 5 mM  glutamate and 5 mM malate as NADH-linked
substrates. Animal care followed the ofﬁcial governmental guide-
lines in compliance with the Federation of Brazilian Societies for
Experimental Biology and was approved by the Ethics Committee
of the Federal University of Rio Grande do Sul, Brazil.
2.3. ROS production
The mitochondrial release of H2O2 was assessed by the Amplex
Red oxidation method. The synaptosomal or mitochondrial frac-
tions (0.1 mg  protein/ml) were incubated in the polarized or
depolarized buffer supplemented with 10 M Amplex Red and
2 units/ml of horseradish peroxidase (HRP). The ﬂuorescence
was monitored at excitation (563 nm)  and emission wavelengths
(587 nm)  using a Spectra Max  M5  microplate reader (Molecular
Devices, Orleans Drive Sunnyvale, CA, USA). Catalase (EC 1.11.1.6)
at 10 U/ml was used as a positive control. Each experiment was
repeated 5 times with different synaptosomal or mitochondrial
preparations.
2.4. Superoxide anion radical scavenging assay
Superoxide anion radical (O2•−) generated by the xan-
thine/xanthine oxidase (EC 1.17.3.2) system was determined
spectrophotometrically by monitoring the reduction products of
nitroblue tetrazolium (NBT) (Nagai et al., 2001). The reaction mix-
ture consisted of 3 mM xanthine, 3 mM EDTA, 15 mM NBT, and
JM-20 (0.5, 1, 3, 5, 25 M ﬁnal concentrations) in 50 mM phosphate
buffer (pH 7.4). After incubation at 25 ◦C for 2 min, the reaction
was initiated by adding 0.05 U/ml xanthine oxidase and carried out
at 25 ◦C for 10 min. The absorbance was measured at 560 nm. The
reaction mixture without xanthine oxidase was used as a blank.
Superoxide dismutase enzyme (SOD, EC 1.15.1.1) at 2 U/ml was
used as positive control. The superoxide anion radical level was
expressed as the percentage of NBT reduction versus control (set at
100%), which did not contain JM-20 or SOD.
The effect of JM-20 on enzyme activity was studied by estimat-
ing the uric acid formation from xanthine after 10 min incubation at
25 ◦C, while absorbance was measured at 295 nm.  The absorbance
was monitored using a Spectra Max  M5 microplate reader (Molec-
ular Devices, Orleans Drive Sunnyvale, CA, USA).
2.5. Oxygen (O2) measurementThe O2 consumption rates were measured polarographically
using high-resolution respirometry (Oroboros Oxygraph-O2 K,
Oroboros Instruments, Innsbruck, Austria). Synaptosomal or mito-
chondrial fractions (0.1 mg/ml) were incubated with polarized
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uffer supplemented with 5 mM succinate plus 2.5 M rotenone,
r 5 mM glutamate plus 5 mM  malate in the absence or pres-
nce of JM-20 for 1 min  at 37 ◦C under continuous stirring.
he respiratory protonophoric uncoupler carbonyl cyanide p-
riﬂuoromethoxyphenyl hydrazone (FCCP, 1 M)  was added, and
he oxygen consumption rates were registered for 10 min.
.6. ATP assay in mitochondria
ATP was determined by the ﬁreﬂy luciferin–luciferase assay sys-
em (Lemasters and Hackenbrock, 1976). Mitochondria (0.1 mg/ml)
ere incubated in depolarized buffer energized with 5 mM gluta-
ate plus 5 mM malate, and supplemented with 1 mM ADP. After
0 min  incubation in the absence or presence of JM-20 (5 M)  or
ligomycin A (1 M),  the mitochondrial suspension (0.1 mg  pro-
ein/ml) was centrifuged at 9000 × g for 5 min  at 4 ◦C and the pellet
reated with 1 ml  of ice-cold 1 M HClO4. After centrifugation at
2,000 × g for 5 min  at 4 ◦C, 100 l aliquots of the supernatants
ere neutralized with 70 l of 2 M KOH, suspended in 100 mM
ris–HCl, pH 7.8 (ﬁnal volume, 1 ml), and centrifuged at 15,000 × g
or 15 min. Bioluminescence was measured in the supernatant
ith a Sigma/Aldrich assay kit, according to the manufacturer’s
nstructions, using an AutoLumat LB953 Luminescence photometer
Perkin-Elmer Life Sciences, Wilbad, Germany).
.7. Electrochemical assays
Electrochemical assays were performed using a BAS CV-27
otentiostat (Bioanalytical System, Inc., West Lafayette, IN, USA)
y employing conventional electrochemical cells with 3 elec-
rodes; the data were recorded using an Omnigraphic 100 recorder
Texas Instruments, Houston, TX, USA). A 0.0314 cm2 geomet-
ic area glassy carbon electrode, which was polished with 1 m
lumina–water suspension and rinsed thoroughly with water and
cetone, was used as the working electrode. A platinum wire was
sed as the counter electrode, and all potentials are referenced to a
odium-saturated silver/silver chloride electrode [Ag/AgCl/KCl(sat)]
ithout regard for the liquid junction potential. The cyclic voltam-
etric studies were performed at a 100 mV/s sweep rate in 5 ml
f 0.1 M phosphate buffer solution (pH 7.0), where aliquots of a
3 M solution of JM-20 in DMSO were added. Because the cyclic
oltammograms were recorded at a window potential including
egative ranges, oxygen-free solution was obtained by bubbling
rgon through the solution. When the potential was scanned, the
nert gas was kept in the solution to ensure that any oxidation
eaction was not initiated by oxygen.
.8. Determination of mitochondrial swelling, membrane
otential ( m) dissipation and cytochrome c release
Mitochondrial swelling was estimated from the decrease in
he apparent absorbance at 540 nm.  The mitochondrial membrane
otential ( m) was estimated spectroﬂuorimetrically using
0 M Safranine O as a probe (Zanotti and Azzone, 1980) at the
95/586 nm excitation/emission wavelength pair. For cytochrome
 estimation, mitochondrial suspensions were centrifuged at
2,000 × g in an Eppendorf centrifuge for 10 min  at 4 ◦C, and the
ifferential absorption spectra (reduced with dithionite/oxidized)
f the supernatants were recorded in a 96-well plate (l = 1 cm).
he cytochrome c absorption extinction coefﬁcient (A550 – A540 nm)
as assumed to be 19.1 (mM  cm)−1 (Kruglov et al., 2008; Nun˜ez-
igueredo et al., 2014b). All of the experiments were performed
ith 1 mg/ml  mitochondrial protein, incubated for 10 min  in depo-
arized buffer (without EDTA) supplemented with 50 M Ca2+ and
 mM succinate plus 2.5 M rotenone, in the absence (Control)
r presence of JM-20 or with a mixture of ADP (250 M)  plusrch Bulletin 109 (2014) 68–76
oligomycin A (1 M),  which is a classical combination that inhibits
the mitochondrial permeability transition in rat brain mitochon-
dria (Saito and Castilho, 2010). The absorbance or ﬂuorescence was
monitored using a Spectra Max  M5  microplate reader (Molecular
Devices, Orleans Drive Sunnyvale, CA, USA).
2.9. Ca2+ inﬂux
Ca2+ inﬂux was monitored spectroﬂuorimetrically using 150 nM
Calcium Green-5N (Molecular Probes, OR, USA) as a probe at
the 506/531 nm excitation/emission wavelength pair (Rajdev and
Reynolds, 1993). The mitochondrial or synaptosomal fractions
(0.1 mg  protein/ml) were incubated for 1 min  with JM-20 (0.5, 1,
3, 5 M),  FCCP (1 M),  Nimodipine (5 M),  or their combinations
before Ca2+ addition (50 M ﬁnal concentration) in depolarized
medium (without EDTA) energized with 5 mM succinate plus
2.5 M rotenone. The ﬂuorescence differences from t = 0 and
t = 600 s after Ca2+ addition (Fluorescence) were recorded using
a Spectra Max  M5  microplate reader (Molecular Devices, Orleans
Drive Sunnyvale, CA, USA).
2.10. Statistical analysis
GraphPad Prism 5.0 software (GraphPad Software Inc., USA)
was used for statistical analyses. The data are expressed as the
mean ± SEM. Comparisons among different groups were performed
using a one-way analysis of variance (ANOVA), followed by the
Newman–Keuls multiple comparison post hoc test. Differences
were considered statistically signiﬁcant at p < 0.05. The IC50 values
were estimated using a non-linear regression algorithm.
3. Results
3.1. Effects of JM-20 on succinate-mediated H2O2 generation in
rat brain synaptosomal and mitochondrial fractions under high K+
depolarizing conditions
Fig. 2 shows that mitochondria (A) and synaptosomes (B) were
responsive to succinate, as evidenced by the increase in the H2O2
generation rate when comparing the control (succinate) and basal
rates. Additionally, JM-20 decreased H2O2 generation in both frac-
tions in a concentration-dependent manner. An excess of catalase
(10 U/ml) over HRP (2 U/ml) used as a positive control, almost com-
pletely reduced H2O2 generation, as expected. Neither succinate
(5 mM)  nor JM-20 (5 M)  interfered with Amplex Red ﬂorescence,
after 10 min  incubation in the absence of HRP (result not shown).
Similar IC50 values were obtained for both preparations (0.91 M),
suggesting that JM-20 may  act as an antioxidant at the mitochon-
drial level.
To improve the H2O2 generation capacity of the synaptosomal
preparation, we  used a buffer with high K+ to depolarize the mem-
branes and to increase the H2O2 production compared with the
polarized buffer (Sims and Blass, 1986). This experimental strategy
alters the membrane permeability during the incubation and per-
mits the detection of classical mitochondrial responses stimulated
by succinate (Sims and Blass, 1986).
3.2. Effects of JM-20 on glucose-mediated H2O2 generation
stimulated by rotenone or by antimycin A in rat brain
synaptosomes under high Na+ polarized conditions
Considering that synaptosomal membranes depolarization by
high K+ may  facilitate JM-20 entrance into synaptosomes, we
also sought to determine the antioxidant effects of JM-20 under
polarized (high Na+) medium conditions. Because such condi-
tions prevent succinate uptake by mitochondria, the rate of H2O2
Y. Nun˜ez-Figueredo et al. / Brain Research Bulletin 109 (2014) 68–76 71
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Fig. 2. JM-20 effects on succinate-induced H2O2 generation in rat brain mitochon-
drial (A) and synaptosomal (in depolarized buffer—high K+) (B) preparations. Brain
mitochondrial or synaptosomal fractions (0.1 mg  proteins/ml) were incubated for
1  min  with JM-20 (0, 0.5, 1, 3 and 5 M)  before succinate (5 mM ﬁnal concentration)
addition. Basal: no succinate and JM-20 addition. Succinate: no JM-20 addition. The
reaction mixture without horse radish peroxidase (HRP) was  used as a blank. The
relative ﬂuorescent units (RFU) were recorded for 10 min, and the slopes (RFU/s/mg
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Fig. 3. JM-20 effects on glucose-induced H2O2 generation stimulated by (A)
rotenone (Rot) or by (B) antimycin A (AA) in rat brain synaptosomes incubated in
high Na+-polarized medium. Rat brain synaptosomal fractions (0.1 mg proteins/ml)
were incubated for 1 min  with JM-20 (0, 0.5, 1, 3 and 5 M)  before rotenone
(2.5 M—(A)) or AA (1 M—(B)) addition. Basal: no glucose and JM-20; glucose:
with glucose and no JM-20. The reaction mixture without horse radish peroxidase
was used as a blank. The relative ﬂuorescent units (RFU) were recorded for 10 min,
and  the slopes (RFU/s/mg protein) were calculated. The data are expressed as the
mean ± S.E.M. (n = 5). Different symbols: p < 0.05 according to the ANOVA and postrotein) were calculated. Excess catalase (10 U/ml) over HRP was used as a posi-
ive control. The data are expressed as the mean ± S.E.M. (n = 5). Different symbols:
 < 0.05 according to the ANOVA and post hoc Newman–Keuls tests.
elease from synaptosomes into the medium was  measured after
he addition of glucose, which is taken up by nerve terminals
nd metabolized and which serves as an energy source (Tretter
t al., 2005). Fig. 3 shows that glucose slightly increased H2O2
roduction in synaptosomes; this effect was  strongly potenti-
ted by the mitochondrial complex I and III inhibitors rotenone
A) and antimycin A (B). Under both of these conditions, JM-
0 also inhibited H2O2 generation in a concentration-dependent
anner and was almost seven times more potent as an antioxi-
ant against rotenone (IC50 = 0.40 M)  compared with antimycin A
IC50 = 2.45 M).  Glucose (10 mM),  rotenone (2.5 M),  or antimycin
 (1 M)  did not affect Amplex Red ﬂuorescence after 10 min  incu-
ation in the absence of HRP (result not shown). As in Fig. 2, catalase
10 U/ml) abolished H2O2 generation.
.3. Effects of JM-20 on H2O2 generation, HRP enzyme catalytic
ctivity or xanthine oxidase-induced generation of superoxide
nion radical in mitochondrial or synaptosomal fraction-free
ediaThe strong antioxidant action of JM-20 against H2O2 genera-
ion observed under our experimental conditions could be due
o (i) its direct reaction with H2O2; (ii) an inhibitory effect onhoc  Newman–Keuls tests.
the HRP enzyme, producing a false-positive effect; (iii) its direct
reaction with superoxide anion radicals (O2•−), preventing H2O2
formation; and/or (iv) its ability to prevent superoxide forma-
tion by competing with oxygen for one-electron reduction in
the mitochondrial electron transport chain. We performed sets
of experiments (in mitochondrial/synaptosomal fraction-free sys-
tems) aiming to understand the antioxidant mechanism of JM-20.
Fig. 4 shows that JM-20 was  unable to direct react with H2O2 (B),
did not interfere with HRP catalytic function (A), and did not react
with xanthine oxidase-generated superoxide anion radicals (C).
This molecule did not interfere with the xanthine oxidase catalytic
activity (result not shown).
3.4. Effects of JM-20 on uncoupled respiration in rat brain
mitochondrial and synaptosomal fractions
Fig. 5 shows that JM-20 inhibited the O2 consumption in isolated
rat brain mitochondrial and synaptosomal fractions, in the pres-
ence of succinate (A) or of glutamate/malate (B). The inhibition in
the presence of the NADH-linked substrates glutamate/malate was
almost two  times greater (approximately 30%) than that elicited
in the presence of succinate, which is a FADH2-related substrate
(approximately 17%). Because FCCP uncouples electron transport
and ATP synthesis, making oxygen consumption independent of
72 Y. Nun˜ez-Figueredo et al. / Brain Research Bulletin 109 (2014) 68–76
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oxidase-generated superoxide anion radicals (C) in mitochondrial/synaptosomal
fraction-free medium with high K+. The relative ﬂuorescent units (RFU) were
recorded for 10 min, and the slopes (RFU/s) were calculated to estimate the HRP
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A, 50 M), was used as antioxidant control. In Fig. 4C, reactions were initiated by
adding xanthine oxidase (0.05 U/ml ﬁnal concentration). SOD (2 U/ml) was  used as
positive control. The results are expressed as the percentage of NBT reduction versus
control (set at 100%), which did not contain JM-20 or SOD. The data are expressed
as the mean ± S.E.M. (n = 5). Different symbols: p < 0.05 according to the ANOVA and
post hoc Newman–Keuls tests.
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Fig. 5. JM-20 effects on uncoupled respiration in mitochondria energized with (A)
succinate (5 mM)  plus rotenone (2.5 M) or with (B) glutamate (5 mM)  plus malate
(5  mM). Synaptosomal or mitochondrial fractions (0.1 mg/ml) were incubated with
polarized buffer supplemented with the respiratory protonophoric uncoupler FCCP
3.6. Electrochemical analysis of JM-20
We  also analyzed the electrochemical behavior of JM-20. A
reduction peak at ca. −0.71 V versus Ag/AgCl/NaClsat in the ﬁrst
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Fig. 6. Effects of JM-20 on ATP levels of isolated rat-brain mitochondria energized
with 5 mM glutamate plus 5 mM malate, 10 min  after incubation in depolarizedTP generation, the observed ability of JM-20 to inhibit the res-
iration of FCCP-treated mitochondria indicated that this molecule
id not inhibit the adenine nucleotide transporter. Since JM-20 was
nable to disrupt mitochondrial membrane organization (result not
hown), these results suggest that JM-20 has the ability to scavenge
lectrons from the mitochondrial energized membrane, diminish-
ng the possibility of electron withdrawal and superoxide anion
adical formation.(1  M)  in the absence or presence of JM-20 for 10 min  at 37 ◦C. The data are expressed
as  the mean ± S.E.M. of three independent experiments. Different symbols: p < 0.05
according to the ANOVA and post hoc Newman–Keuls tests.
3.5. Effects of JM-20 on mitochondrial ATP levels
To clarify whether the inhibitory effect of JM-20 on uncoupled
respiration may interfere with the ATP synthesis in mitochondria, it
was evaluated its effects on ATP levels. After 10-min incubation JM-
20 did not affect the ATP levels of isolated rat-brain mitochondria
(Fig. 6). It denotes none energetic impairment by JM-20 at com-
parable experimental condition to that eliciting antioxidative and
Calcium protection.medium supplemented with 1 mM ADP, as described in Materials and methods.
Mitochondria (0.1 mg/ml) were incubated in the absence (Control) or presence of
JM-20 (5 M).  Oligomycin A (1 M),  the classic inhibitor of the F1FO ATPase activity,
was used as a positive control. Different symbols: p < 0.05 according to the ANOVA
and  post hoc Newman–Keuls tests.
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Fig. 7. Cyclic voltammograms of JM-20 (33 M)  in 0.1 M phosphate buffer solution
(pH 7.0). A glassy carbon working electrode with a geometric area of 0.0314 cm2
and a scan rate of 100 mV/s was used.
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Fig. 8. Effects of JM-20 on Ca2+-induced mitochondrial swelling (A), membrane
potential ( m) dissipation (B), and cytochrome c release (C). Rat brain mitochon-
dria  (1 mg/ml) were incubated for 10 min  in depolarized medium (without EDTA)
supplemented with 50 M Ca2+, 5 mM succinate and 2.5 M rotenone in the absence
(Ca2+-trace a) or the presence of JM-20 (1, 3 and 5 M-traces b, c and d, respectively)
or  the combination of ADP (250 M)  plus oligomycin A (Olig. A, 1 M)  (trace e). For
 m estimation, 10 M Safranine O was incorporated into the medium. In panel B,
the results were expressed as % versus 100%  m dissipation induced by 1 M car-
bonyl cyanide p-triﬂuoromethoxyphenyl hydrazone (FCCP, 1 M).  For cytochrome c
release estimation, the mitochondrial suspension was sediment by high-speed cen-
trifugation after a 10 min  incubation with JM-20 (5 M)  or ADP + Olig. A. Traces in
(A) are representative of ﬁve experiments conducted with different mitochondrialathodic scan (Fig. 7) was observed for JM-20; we ascribed this
eak to a nitro reduction mechanism (Nún˜ez-Vergara et al., 1997).
he JM-20 cathodic peak potential value is close to that of oxygen
–0.8 V), suggesting similar electron afﬁnities and making JM-20 an
xygen competitor for electrons under low oxygen concentration.
hese ﬁndings may  explain the antioxidant effect of JM-20 and its
bility to inhibit uncoupled respiration.
.7. Effects of JM-20 on Ca2+-mediated rat brain mitochondrial
welling, membrane potential dissipation and cytochrome c
elease
A key pathogenic event during stroke is the opening of
he mitochondrial permeability transition pores (mPTP) in the
nner mitochondrial membrane (Hirsch et al., 1998). In the next
et of experiments, we assessed the effects of JM-20 on Ca2+-
nd Pi-induced mPTP opening, as estimated by the swelling of
uccinate-energized rat brain mitochondria. This classic swelling
echnique monitors the net inﬂux of the osmotic support asso-
iated with a non-speciﬁc increase in membrane permeability.
ig. 8A shows that 50 M Ca2+ plus 5 mM Pi induced mitochon-
rial swelling, as revealed by the large decrease in the turbidity of
he mitochondrial suspension at 540 nm (trace a: control without
M-20). This swelling was associated with a faster mitochon-
rial membrane potential dissipation (Fig. 8B, Ca2+). JM-20 (5 M)
lmost completely inhibited both swelling and mitochondrial
embrane potential dissipation (trace d, Fig. 8A and B, respec-
ively) in a similar manner to the protection elicited by the classic
PTP inhibitor mixture ADP plus oligomycin A (trace e, Fig. 8A and
, respectively).
Cytochrome c release from the mitochondria plays an impor-
ant role in cell death (Li et al., 1997). Because we previously
emonstrated that JM-20 prevented neuronal cell death in different
aradigms associated with the ischemic process (Nun˜ez-Figueredo
t al., 2014a), next, we assessed the potential involvement of
ytochrome c release inhibition in JM-20 effects in this study.
a2+/Pi overload induced a substantial release of cytochrome c from
at brain mitochondria (Fig. 8C); this effect was almost completely
bolished by ADP plus oligomycin A. JM-20 (5 M)  prevented this
elease.preparations. The data are expressed as the mean ± S.E.M. (n = 5). Different symbols:
p  < 0.05 according to the ANOVA and post hoc Newman–Keuls tests.
3.8. Effects of JM-20 on Ca2+ inﬂux into rat brain mitochondrial
or synaptosomal fractions
JM-20 inhibited Ca2+ inﬂux in succinate-energized rat brain
mitochondrial and synaptosomal fractions in a concentration-
dependent manner (Fig. 9A). The co-incubation of FCCP with
increasing concentrations of JM-20 did not increase the inhibitory
potency of either compound alone (Fig. 9B), suggesting that the Ca2+uptake inhibition elicited by JM-20 may  be localized at the mito-
chondrial level. In fact, the well-known L-type Ca2+ channel blocker
nimodipine produced approximately 50% Ca2+ uptake inhibition;
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Fig. 9. JM-20 effects on Ca2+ inﬂux into mitochondria or synaptosomes (A) or synap-
tosomes alone (B). The mitochondrial or synaptosomal fractions (0.1 mg  protein/ml)
were incubated for 1 min  with JM-20 (0.5, 1, 3, 5 M),  FCCP (1 M),  nimodip-
ine  (Nimo, 5 M)  or their combinations in depolarizing buffer (without EDTA),
before Ca2+ (50 M) addition. The ﬂuorescence differences from t = 0 and t = 600 s
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wfter Ca2+ addition ( Fluorescence) were recorded. The data are expressed as the
ean ± S.E.M. (n = 5). Different symbols: p < 0.05 according to the ANOVA and post
oc  Newman–Keuls tests.
his effect was potentiated by the mitochondrial uncoupler FCCP
r by JM-20 co-incubation, thus strengthening the mitochondrial
ocalization of JM-20 inhibitory effects on Ca2+ uptake.
. Discussion
Numerous pieces of evidence show that ROS are involved in
rain lesions, including those lesions due to cerebral ischemia-
eperfusion (Allen and Bayraktutan, 2009; Chen et al., 2011;
anzanero et al., 2013). Mitochondria are the primary intra-
ellular source of ROS because these organelles generate many
xidative-reduction reactions and use massive amounts of oxygen
Adam-Vizi, 2005; Lin and Beal, 2006). When anoxia is followed
romptly by reperfusion, the resulting increase in oxygen supply
eads to ROS overproduction (Han et al., 2001; Liu et al., 2002).
n ischemic tissues, several studies have established a direct role
or ROS in oxidative damage to lipids, proteins, and nucleic acids
Allen and Bayraktutan, 2009; Chen et al., 2011; Manzanero et al.,
013). Thus, mitochondria are both the initiators and the ﬁrst tar-
ets of oxidative stress. Mitochondrial damage can lead to cell
eath, given the role of mitochondria in energy metabolism and
n calcium homeostasis, as well as the ability of mitochondria to
elease pro-apoptotic factors, such as cytochrome c and apoptosis-
nducing factor (AIF) (Fiskum, 2000; Fiskum et al., 1999; Lau and
ymianski, 2010; Niizuma et al., 2009). Thus, antioxidants targeting
itochondrial oxidative stress and mitoprotectors are the primary
ocus of neuroprotectant research. In this work, we observed that
M-20, which is a novel benzodiazepine-dihydropyridine hybrid
olecule, is a strong antioxidant that acts at both synaptosomal
nd mitochondrial levels. Its antioxidant action was  not related
o its ability to scavenge superoxide anion radicals or hydrogen
eroxide but to its strong electron afﬁnity given by its low redox
otential similar to that of oxygen. This electrochemical character-
stic endows JM-20 with the ability to scavenge electrons from the
itochondrial electron transport chain (METC) or even to compete
ith oxygen for the electrons released from mitochondria, thusrch Bulletin 109 (2014) 68–76
preventing ROS formation. We  believe that the presence of a nitro
group in the JM-20 dihydropyridine portion may  be responsible
for this antioxidant action. In this regard, the antioxidant effects of
several dihydropyridine derivatives on Fe3+/ascorbate-stimulated
lipid peroxidation in rat brain slices has been reported (Díaz-
Araya et al., 1998). Additionally, a potent reduction of alkylperoxyl
and ABTS radicals by 1,4-dihydropyridines involving an electron
transfer process has been documented (Yán˜ez et al., 2004). In
fact, several 1,4-dihydropyridines inhibit oxygen consumption by
T. cruzi Tulahueı´n strain epimastigotes. The drugs with higher
electron-afﬁnity produced greater inhibition than did those drugs
with lower electron-afﬁnity (Nún˜ez-Vergara et al., 1997). These
nitro-containing molecules could be reduced at the mitochondrial
electron transport chain from parasites, thus inhibiting mitochon-
drial respiration. In the present study, we  observed that JM-20
inhibited uncoupled respiration in isolated rat brain mitochondria,
producing two times greater inhibition when glutamate/malate
(complex I-linked substrates) were used as the energy source. This
ﬁnding suggests that JM-20 reduction by the METC may involve the
entire chain, particularly the upper levels of transporters where the
electrochemical redox values are lower.
It is important to note that the IC50 value for the uncoupled
respiration inhibition by JM-20 (12.31 M)  is more than 10 times
higher than those for the antioxidant effects elicited by JM-20 on
mitochondria or synaptosomes under depolarizing or polarizing
conditions (Figs. 2 and 3). Furthermore, high thresholds of inhi-
bition of activity of Complexes I, III and IV (more than 70%), are
needed before major changes in ATP production occur in isolated
brain mitochondria (Kilbride et al., 2011; Rossignol et al., 1999;
Mazat et al., 2001). These circumstances make improbable that JM-
20 interferes with mitochondrial respiration and ATP synthesis at
antioxidative or mitoprotective concentrations as evidenced by the
lack of effect of this molecule on the ATP output in tightly coupled
mitochondria (Fig. 6).
Under polarized conditions (high Na+ medium) where synapto-
some membrane integrity is preserved, JM-20 also elicited strong
antioxidant actions and was more potent when H2O2 production
was stimulated by the mitochondrial complex I inhibitor rotenone.
Because we observed that JM-20 did not react with H2O2, this
result suggests that this molecule crosses synaptosomal mem-
branes and targets mitochondria, thus preventing ROS formation.
Because reactive oxygen species generated from mitochondria have
been implicated in acute brain injuries, such as stroke (Manzanero
et al., 2013; Niizuma et al., 2009), and because inhibiting ROS pro-
duction at the source rather than scavenging the already produced
oxidant agents, is already displaying positive outcomes (Hill et al.,
2012; Manzanero et al., 2013), JM-20 could be a potential candidate
for antioxidant therapy after ischemic brain damage.
ROS generation reduction at the mitochondrial level is not the
only strategy to protect neurons after an ischemic event. Sev-
eral aspects of mitochondrial function, which are not necessarily
linked with ROS generation, could also be modulated to prevent
mitochondrial impairment and mitochondrial-mediated apopto-
sis signaling initiation. In this regard, the excessive mitochondrial
Ca2+ loading following an ischemic insult may  result in mito-
chondrial permeability transition pore (mPTP) opening (Sullivan
et al., 2005). In turn, this mPTP opening will result in a massive
leak of protons and complete and immediate dissipation of the
mitochondrial membrane potential, indicating a commitment to
death. Cytochrome c release from the inter-membrane space of
the mitochondria to the cytosol is one of the critical events that
occur during apoptotic neuronal cell death (Fiskum, 2000; Lau
and Tymianski, 2010). Because diazepam and nimodipine, both of
which exhibit structural similarities to JM-20, have been reported
to protect neuronal cells in different experimental models of brain
ischemia via mitochondrial mechanisms (Sarnowska et al., 2009;
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aya et al., 2000), in the present study, we also addressed the
dea that brain mitochondria are potential pharmacological tar-
ets for the neuroprotective action of JM-20. We  also demonstrated
he protective effect of JM-20 against Ca2+-induced mPTP open-
ng, the dissipation of the membrane potential and the inhibition
f Ca2+-induced cytochrome c release from rat brain mitochondria.
M-20 also signiﬁcantly prevented mitochondrial Ca2+ inﬂux, which
ay have been responsible for the Ca2+-induced mitochondrial
welling. In this regard, abnormal Ca2+ accumulation by neuronal
itochondria in response to excitotoxic levels of excitatory neu-
otransmitters, such as glutamate, is an important mediator of
itochondrial dysfunction and of delayed cell death (Drago et al.,
011; Fiskum, 2000). Thus, JM-20-mediated protection against
a2+-induced mitochondrial impairment and its neuroprotective
ffects may  include its ability to prevent mitochondrial Ca2+ inﬂux.
otably, the inhibition of Ca2+ inﬂux into synaptosomes by JM-20
ollowed the inhibitory patterns of the mitochondrial uncoupler
CCP and was different from that of nimodipine, which is a well-
nown L-type Ca2+ channel blocker. Indeed, the combination of
CCP with increasing concentrations of JM-20 did not induce fur-
her Ca2+ uptake inhibition greater than that induced by JM-20
r by FCCP alone in synaptosomes. The combination of JM-20 or
CCP plus nimodipine prompted a more than 30% increase in Ca2+
nﬂux inhibition. These results suggest that the synaptosomal inhi-
ition of Ca2+ uptake elicited by JM-20 is most likely related to
ts ability to block mitochondrial Ca2+ entry, similar to FCCP. This
nhibition of Ca2+ uptake at the mitochondrial level may  increase
ytoplasmic Ca2+ concentrations in synaptosomes, thus leading
o a diffusional impairment of further synaptosomal Ca2+ inﬂux.
herefore, although the chemical structure of JM-20 includes a
ihydropyridine moiety, JM-20 seems to be unable to block voltage-
ependent Ca2+ channels at synaptosomal membranes under our
xperimental conditions. Recently, we observed that the strong
europrotective in vivo effect of JM-20 against an experimental
odel of ischemic brain damage was related to lower Ca2+ accu-
ulation into the brain mitochondria (Nun˜ez-Figueredo et al.,
014b). In this previous work, we raised the hypotheses that JM-
0 could be inhibiting the Ca2+ uptake at neuronal membranes,
t mitochondrial membranes, or at both levels. The present results
uggest that this molecule is most likely acting at the mitochondrial
evel.
In conclusion, this work reveals two primary aspects of the neu-
oprotective mechanism of JM-20: (i) its strong antioxidant action
nd (ii) its protective effects against Ca2+-induced impairment,
hich are both elicited at the mitochondrial level. The combination
f two privilege structures into one molecule, a dihydropyridine
oiety with a nitroaromatic group and a benzodiazepine ring sup-
orting a net positive charge and a high level of lipophilicity, may
llow the new chemical entity to cross the blood-brain barrier and
ell membranes, selectively targeting mitochondria. Recently, we
bserved important anxiolytic and sedative effects of JM-20 on dif-
erent in vivo experimental models with a lack of toxic effects,
ndicating its ability to reach the central nervous system at low
oses (Figueredo et al., 2013). Because mitochondria are consid-
red one of the important sources and targets of neuronal cell
eath signaling after an ischemic insult, JM-20 has the potential to
ucceed in mitochondrion-targeted strategies to combat ischemic
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